无动于衷和护理人员负担之间的关联在肌缩性侧面硬化症患者:一个横截面研究
Zhenxiang Gong1, Wenhua Deng1, Zehui Li1
1Department of Neurology, Huazhong University of Science and Technology Tongji Medical College Tongji Hospital, Wuhan, Hubei, China.
BMJ open
|September 4, 2024
概括
漠不关心,抑郁和焦虑显著增加了肌缩侧面硬化症 (ALS) 护理人员的负担. 漠不关心会调解抑郁和焦虑对护理人员负担的影响,强调需要在ALS护理中对漠不关心进行管理.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 护理人员支持护理人员支持
背景情况:
- 肌缩性侧面硬化症 (ALS) 对患者和护理人员来说构成了复杂的挑战.
- 了解影响护理人员负担的心理因素对于有效的支持至关重要.
研究的目的:
- 检查ALS患者的冷漠,认知障碍,抑郁,焦虑和护理人员负担之间的关联.
- 调查冷漠在患者心理状态和护理人员负担之间的关系中的调解作用.
主要方法:
- 一项涉及109名ALS患者及其主要护理人员的横截面研究.
- 评估患者的冷漠,认知,抑郁和焦虑,使用经过验证的尺度.
- 使用Zarit负担采访对照顾者负担的评估.
- 统计分析包括后勤回归和调解模型.
主要成果:
- 较高的护理人员负担与ALS患者的抑郁,焦虑和冷漠性增加有显著的关联.
- 无动于衷被确定为护理人员负担增加的独立风险因素.
- 漠不关心完全介绍了抑郁症和照顾者负担之间的联系,部分介绍了焦虑和照顾者负担之间的联系.
结论:
- 漠不关心,抑郁和焦虑会对ALS患者的照顾者负担产生负面影响.
- 漠不关心起着重要的调解作用,强调了它在患者护理人员二元关系中的重要性.
- 临床策略应优先确定和管理ALS中的冷漠,以减轻护理人员的痛苦.
相关概念视频
Cross-bridge Cycle
117.1K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.1K
Lazarus's Cognitive Appraisal Theory
198
Cognitive psychologist Richard Lazarus proposed the cognitive-mediational theory of emotions, which emphasizes how individuals' assessments of stressors significantly affect their experience of stress. According to Lazarus, the stress response is determined by a two-step appraisal process: primary appraisal and secondary appraisal. These cognitive appraisals help individuals evaluate the potential impact of a stressor and determine the adequacy of their coping resources.
Primary Appraisal:...
Primary Appraisal:...
198
Negative and Cognitive Symptoms of Schizophrenia
46
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
46
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Autism Spectrum Disorder
77
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
77
Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499


